| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 731701 | 1[(4-n-butyloxyCarbonyl)piperazine-1-yl]diazene-1-ium-1,2-di olate | 0.0135714101922724 | 0.10497495 |
| NSC 733149 | Null | 0.0135714101922724 | 0.4815462 |
| NSC 750050 | Null | 0.0135714101922724 | 0.073660984 |
| NSC 752278 | 2,7-Bis-[2-(2,3,4-trimethoxy-benzylamino)-ethyl]-benzo[lmn][3,8]phenanthroline-1,3,6,8-tetraone di-p-toluensulfonate salt | 0.0135714101922724 | 0.3393985 |
| NSC 753456 | 2-4-[5-(3,5-dimethoxyphenyl)-1H-1-imidazolyl]phenyl-5,6,7-trimethoxy-1,3-benzothiazole | 0.0135714101922724 | 0.57946376 |
| NSC 113497 | 16,17-Seco-24-nor-5.alpha.,13.alpha.,14.beta.,17.alpha.-chola-1,20,22-trien-16-oic acid, 14,15.beta.:21,23-diepoxy-7.alpha.,17-dihydroxy-4,4,8-trimethyl-3-oxo-, 16,17-lactone, acetate (8CI) | 0.0139796580235792 | 0.39594234 |
| NSC 129794 | Ethanesulfonic acid, compd. with 2-chloro-5-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) | 0.0139796580235792 | 0.22056432 |
| NSC 173552 | L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate | 0.0139796580235792 | 0.45982874 |
| NSC 244404 | Null | 0.0139796580235792 | 0.41561466 |
| NSC 30915 | Null | 0.0139796580235792 | 0.36877826 |